PeptideStack
5.2kquestions
20kanswers
220users

Why does hydrolysis accelerate at 4 °C rather than proceeding linearly?

Asked 19 Jun 2024Modified 22 months agoViewed 24k times
6

Details up front: hydrolysis · 4 °C.

I can predict the outcome but I cannot explain it, which means I will get the next case wrong.

I would like to know how confident the field actually is about this.

What is actually going on here, physically?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
hplc
hplc

Reverse-phase high-performance liquid chromatography, the workhorse purity method. Column chemistry, mobile-phase choice, gradient slope,…

503 questions
shareeditfollowflag
LM
askedlucia_marchetti19k2719 Jun 2024
4Worth saying whether the vial has been opened, because that starts a different clock. – Dr_Wren_Halliday 5 months ago
add a comment

5 Answers

Sorted by votes
34

Because temperature enters the rate constant through an exponential, so equal steps in temperature multiply the rate instead of adding to it. Arrhenius puts the rate proportional to exp(−Ea/RT); the working approximation is a doubling per 10 K, which takes 5, 15, 25 and 35 °C to multipliers of 1, 2, 4 and 8. The steps in temperature are equal and the steps in rate are not, and that is the whole of the observation. At 4 °C the same rule gives about 0.9 times the refrigerated rate, and another 10 K would roughly double it again. Backbone amide bonds cleave, so every product is shorter than the parent and the mass ladder they leave behind is the evidence that it happened. Ea differs by route, so the ranking of routes changes with temperature too — which is why accelerated data extrapolates badly and why nobody should read a 40 °C study as a fast version of a 5 °C one.

The short version: water enables most of it, oxygen enables oxidation, surfaces enable adsorption, and agitation enables aggregation.

Light exposure matters for tryptophan-containing sequences and for anything with a chromophore. Amber vials and a closed box are free mitigations.

Aggregation is physical: peptides unfold at air-liquid interfaces and associate. Shaking maximises that interface, which is why swirling and shaking produce visibly different outcomes on the same vial.

Aggregation at air-liquid interfaces is established from surface-tension and particle-count studies and is the basis for anti-agitation handling guidance.

At dilute concentrations, suspect adsorption before you suspect chemistry.

shareimprove this answerflag
KA
answeredkwn_analytical147k3586 Sept 2024
4I have kept vials both ways for a year and this matches what I saw. – t_oyelaran 2 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
24

The relevant point is that a mass shift of plus one dalton is deamidation and plus sixteen is oxidation, so degradation is often visible in a mass spectrum if anyone looks.

Hydrolysis cleaves the backbone, most readily at aspartate-proline and aspartate-glycine sequences, and is acid-catalysed. In a dry solid it barely proceeds at all.

The underlying point is that oxidation targets methionine, cysteine and tryptophan, adding sixteen daltons per oxygen. It is catalysed by trace metals and promoted by dissolved oxygen and by light.

Swirl, never shake. Aggregation is a handling problem more than a time problem.

shareimprove this answerflag
DZ
answeredDr_Marek_Zielinski27k2726 Aug 2024
Worth adding that residual moisture predicts this better than any printed date. – deamidation_watch 7 months ago
The desiccant point is under-appreciated and costs nothing to act on. – Dr_Lena_Ostrowska 5 months ago
add a comment
19

Answer first: the degradation pathways worth knowing are hydrolysis, deamidation, oxidation, aggregation and adsorption, and each has a different trigger and a different mitigation.

Adsorption onto glass and plastic is significant at low concentrations — micrograms per millilitre — and negligible at milligrams per millilitre. It is the usual explanation for an apparent loss in a dilute preparation.

A mass spectrum resolves most of this: minus eighteen is dehydration or succinimide, plus one is deamidation, plus sixteen is oxidation, and an unchanged mass with a shifted retention time is an isomer.

Cold, dry, dark, still. Those four words cover most of the mitigation.

shareimprove this answerflag
JF
answeredjuliette_farnese13k3828 Sept 2024
16

The honest answer is that most reported "degradation" is adsorption and dilution error rather than chemistry.

Deamidation converts asparagine or glutamine to the corresponding acid via a succinimide intermediate, adding one dalton. It is base-catalysed, accelerates above neutral pH and is the dominant aqueous pathway for many peptides.

Metal-catalysed oxidation of methionine is documented across peptide and protein formulations and is why chelators appear in some formulations.

A mass spectrum names the pathway. Plus one, plus sixteen, minus eighteen.

shareimprove this answerflag
LC
answeredlyoph_cake78k26717 Sept 2024
7Adding for future readers: the domestic leg after delivery is the part you control. – tobias_maartens 8 months ago
6Does the same reasoning apply to material already in solution, or is that a different curve? – k_szabo 6 months ago
add a comment
14

This is answerable from the chemistry rather than from anecdote, which is unusual and welcome.

Freeze-thaw cycling drives aggregation through concentration at the ice interface and pH shifts as buffer components crystallise out at different rates. Each cycle costs something.

Sequence decides which pathways are even available. Check the residues.

edited 5 Aug 2024 by micron22 — clarified the distinction between purity and content

shareimprove this answerflag
MI
answeredmicron2222k3824 Jul 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.